Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Celltech and Biogen collaborate on CDP-571

April 25, 2002

FDA advisory panel recommends reintroduction of Lotronex for irritable bowel syndrome

April 25, 2002

LY-582563/MCC-478 more active than PMEA against wild-type and mutant HBV

April 25, 2002

Interferon omega safe and effective in HCV-infected patients

April 25, 2002

Promising in vitro anti-HBV activity described for MCC-478 this week at JSGE meeting

April 24, 2002

Patient enrollment completed in phase II trial of interferon omega in chronic hepatitis C

April 22, 2002

Nonabsorbable antibiotics for treatment of gastrointestinal disorders

April 19, 2002

Phase I/II trial of Civacir to prevent HCV reinfection following liver transplant

April 19, 2002

Phase III U.S. trials start for hepatitis C combination therapy in nonresponders

April 17, 2002

Adolor's alvimopan will be codeveloped with GSK

April 17, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Chengdu Mfs Pharma synthesizes new compounds for pain
BioWorld Science
Chengdu Mfs Pharma Co. Ltd. has prepared and tested compounds for the potential treatment of pain, sleep disorder and status epilepticus epilepsy as well as for...